ADAMTS13 and thrombotic thrombocytopenic purpura: Accordingly, fundamental treatments for TTP involve removal of the ADAMTS13 inhibitor by plasma exchange and supplementation with ADAMTS13 or through the administration of fresh frozen plasma (FFP).